Kenyan Health Patient Information Leaflet
Therapeutic agent (verify pharmacological class)
Therapeutic use is agent- and indication-specific within the class (Therapeutic agent (verify pharmacological class)). Use according to culture results, national guidelines (Kenya STG/EML where applicable) and the current product SmPC. Dehydration (treatment and prophylaxis)
According to the extent of fluid loss. Usually 200 - 400ml solution after every loose motion. Infant: 1-1 times usual feed volume. Children: 200ml after every loose motion.
Adverse reactions vary by agent. Counsel on common predictable effects and serious warning symptoms (allergy, severe rash, jaundice, unusual bleeding, severe GI symptoms, neurological changes). Report suspected ADRs via national pharmacovigilance channels.
Store as labelled. Keep out of reach of children.